https://www.selleckchem.com/pr....oducts/sch772984.htm
72 (95% CI 3.48, 6.40; 0.00001) compared with those without irAEs. Subgroup analyses suggested that the prognostic role of irAEs was associated with cancer types and region, but not irAEs types. The landmark analysis of OS revealed that there is a non-proportional (early) effect of irAEs on OS in ICI-treated cancer patients (landmark 12 weeks, HR = 1.08; 95% CI 0.89, 1.30; = 0.46). Our findings suggest that the occurrence of irAEs could be a prognostic factor for cancer patients who were treated with ICIs. Our findings sug
Like
Comment
Share
